PR Newswire
SAN DIEGO, Dec. 9, 2016
SAN DIEGO, Dec. 9, 2016 /PRNewswire/ -- aTyr Pharma, Inc.
(Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address
severe, rare diseases, today announced that senior management will participate in a fireside chat at the upcoming BMO
Prescriptions for Success Healthcare Conference at the InterContinental Barclay Hotel in New York
City on Wednesday, December 14, 2016, at 4:20 p.m. ET.
About aTyr Pharma
aTyr Pharma is engaged in the discovery and clinical development of innovative medicines for patients suffering from severe
rare diseases using its knowledge of Physiocrine biology, a newly discovered set of physiological modulators. The Company's lead
candidate, Resolaris™, is a potential first-in-class intravenous protein therapeutic for the treatment of rare myopathies with an
immune component. Resolaris is currently in a Phase 1b/2 trial in adult patients with limb-girdle muscular dystrophy 2B (LGMD2B
or dysferlinopathies) or FSHD and a Phase 1b/2 trial in patients with an early onset form of FSHD. In addition, Resolaris is
currently being evaluated in two Phase 1b/2 long-term safety extension studies, the first in patients with adult FSHD and the
second in patients with LGMD2B, adult FSHD or early onset FSHD. To protect this pipeline, aTyr has built an intellectual property
estate comprising over 80 issued or allowed patents and over 230 pending patent applications that are owned or exclusively
licensed by aTyr, including over 300 potential Physiocrine-based protein compositions. aTyr's key programs are currently focused
on severe, rare diseases characterized by immune dysregulation for which there are currently limited or no treatment options. For
more information, please visit http://www.atyrpharma.com.
Contact:
Mark Johnson
Sr. Director, Investor Relations
mjohnson@atyrpharma.com
858-223-1163
Logo - http://photos.prnewswire.com/prnh/20120809/MM55538LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/atyr-pharma-to-present-at-the-bmo-prescriptions-for-success-healthcare-conference-300375951.html
SOURCE aTyr Pharma, Inc.
